INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 111 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $0 | – | 26 | 0.0% | 0.00% | – |
Q3 2017 | $0 | -100.0% | 26 | -98.3% | 0.00% | – |
Q2 2017 | $2,000 | -60.0% | 1,501 | +1.8% | 0.00% | – |
Q1 2017 | $5,000 | +150.0% | 1,475 | +6.7% | 0.00% | – |
Q4 2016 | $2,000 | 0.0% | 1,382 | -10.3% | 0.00% | – |
Q3 2016 | $2,000 | 0.0% | 1,540 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | -77.8% | 1,540 | -6.6% | 0.00% | – |
Q1 2016 | $9,000 | -35.7% | 1,648 | -7.4% | 0.00% | – |
Q4 2015 | $14,000 | -6.7% | 1,780 | 0.0% | 0.00% | – |
Q3 2015 | $15,000 | – | 1,780 | +4464.1% | 0.00% | – |
Q2 2015 | $0 | -100.0% | 39 | 0.0% | 0.00% | – |
Q1 2015 | $1,000 | 0.0% | 39 | 0.0% | 0.00% | – |
Q4 2014 | $1,000 | 0.0% | 39 | 0.0% | 0.00% | – |
Q3 2014 | $1,000 | – | 39 | 0.0% | 0.00% | – |
Q2 2014 | $0 | -100.0% | 39 | -97.4% | 0.00% | -100.0% |
Q4 2013 | $21,000 | +31.2% | 1,500 | +50.0% | 0.00% | 0.0% |
Q2 2013 | $16,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
Bleichroeder LP | 250,000 | $530,000 | 0.10% |
PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |